Keith S. Bahjat

4.7k total citations · 1 hit paper
46 papers, 3.3k citations indexed

About

Keith S. Bahjat is a scholar working on Immunology, Biotechnology and Oncology. According to data from OpenAlex, Keith S. Bahjat has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 14 papers in Biotechnology and 13 papers in Oncology. Recurrent topics in Keith S. Bahjat's work include Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer Research and Treatments (9 papers). Keith S. Bahjat is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer Research and Treatments (9 papers). Keith S. Bahjat collaborates with scholars based in United States, Germany and France. Keith S. Bahjat's co-authors include Anna Schwendeman, James J. Moon, Rui Kuai, Lukasz J. Ochyl, Thomas W. Dubensky, Dirk G. Brockstedt, Marka R. Crittenden, Shelly Bambina, Michael J. Gough and Benjamin Cottam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Keith S. Bahjat

46 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Designer vaccine nanodiscs for personalized cancer immunotherapy

2016 879 citations Rui Kuai, Lukasz J. Ochyl et al. Nature Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith S. Bahjat United States	24	2.2k	1.1k	858	521	408	46	3.3k
Amy Hobeika United States	34	2.5k 1.1×	1.7k 1.5×	2.0k 2.4×	200 0.4×	130 0.3×	90	4.2k
Martin Löwer Germany	24	2.5k 1.1×	1.8k 1.6×	1.9k 2.2×	234 0.4×	101 0.2×	44	4.1k
Na Li China	25	1.0k 0.5×	1.9k 1.7×	1.6k 1.8×	890 1.7×	86 0.2×	112	3.4k
Timothy M. Clay United States	41	3.2k 1.4×	2.2k 1.9×	2.6k 3.1×	440 0.8×	234 0.6×	97	5.9k
Tibor Keler United States	46	4.2k 1.9×	2.4k 2.1×	1.9k 2.2×	149 0.3×	171 0.4×	153	6.0k
Roger P.M. Sutmuller Netherlands	24	3.4k 1.5×	1.5k 1.4×	773 0.9×	199 0.4×	154 0.4×	30	4.5k
Sebastian Kreiter Germany	29	2.9k 1.3×	1.9k 1.7×	2.6k 3.0×	214 0.4×	130 0.3×	64	4.6k
Omkar U. Kawalekar United States	13	1.8k 0.8×	3.1k 2.8×	1.3k 1.5×	1.1k 2.1×	124 0.3×	20	4.5k
Dirk G. Brockstedt United States	29	3.5k 1.6×	2.0k 1.8×	1.3k 1.5×	310 0.6×	794 1.9×	77	5.0k
Lélia Delamarre United States	28	3.9k 1.8×	1.5k 1.3×	2.0k 2.3×	269 0.5×	82 0.2×	50	5.4k

Countries citing papers authored by Keith S. Bahjat

Since Specialization

Citations

This map shows the geographic impact of Keith S. Bahjat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Bahjat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Bahjat more than expected).

Fields of papers citing papers by Keith S. Bahjat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Bahjat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Bahjat. The network helps show where Keith S. Bahjat may publish in the future.

Co-authorship network of co-authors of Keith S. Bahjat

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Bahjat. A scholar is included among the top collaborators of Keith S. Bahjat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Bahjat. Keith S. Bahjat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alice, Alejandro, Gwen Kramer, Shelly Bambina, et al.. (2021). Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production. Scientific Reports. 11(1). 16347–16347. 6 indexed citations

Bambina, Shelly, Alejandro Alice, Kyra D. Zens, et al.. (2019). A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity. PLoS ONE. 14(1). e0209153–e0209153. 19 indexed citations

Sanborn, Rachel E., Brian C. Boulmay, Rui Li, et al.. (2017). P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC. Journal of Thoracic Oncology. 12(1). S873–S873. 2 indexed citations

Koguchi, Yoshinobu, et al.. (2016). A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood. Journal of Visualized Experiments. e53485–e53485. 4 indexed citations

Kuai, Rui, Lukasz J. Ochyl, Keith S. Bahjat, Anna Schwendeman, & James J. Moon. (2016). Designer vaccine nanodiscs for personalized cancer immunotherapy. Nature Materials. 16(4). 489–496. 879 indexed citations breakdown →

Koguchi, Yoshinobu, Helena Hoen, Shelly Bambina, et al.. (2015). Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab. Cancer Research. 75(23). 5084–5092. 39 indexed citations

Baird, Jason R., David J. Friedman, Benjamin Cottam, et al.. (2015). Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors. Cancer Research. 76(1). 50–61. 201 indexed citations

Bambina, Shelly, et al.. (2013). A Self-Help Program for Memory CD8+ T Cells: Positive Feedback via CD40-CD40L Signaling as a Critical Determinant of Secondary Expansion. PLoS ONE. 8(5). e64878–e64878. 10 indexed citations

Krebs, Philippe, Michael J. Barnes, Kristin Lampe, et al.. (2009). NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses. Blood. 113(26). 6593–6602. 108 indexed citations

10.

Škoberne, Mojca, Alice Yewdall, Keith S. Bahjat, et al.. (2008). KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. Journal of Clinical Investigation. 118(12). 3990–4001. 35 indexed citations

11.

Bahjat, Keith S., Rodney A. Prell, Heather E. Allen, et al.. (2007). Activation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease. The Journal of Immunology. 179(11). 7376–7384. 21 indexed citations

12.

Brockstedt, Dirk G., Meredith L. Leong, Keith S. Bahjat, et al.. (2007). Live-attenuated L. monocytogenes encoding mesothelin for immunotherapy of patients with pancreas and ovarian cancers. 67. 1874–1874. 3 indexed citations

13.

Yoshimura, Kiyoshi, Ajay Jain, Heather E. Allen, et al.. (2006). Selective Targeting of Antitumor Immune Responses with Engineered Live-Attenuated Listeria monocytogenes. Cancer Research. 66(2). 1096–1104. 48 indexed citations

14.

Janssen, Edith M., Koichi Tabeta, Michael J. Barnes, et al.. (2006). Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway. Immunity. 24(6). 787–799. 81 indexed citations

15.

Oberholzer, Caroline, Sven K. Tschoeke, Keith S. Bahjat, et al.. (2005). In Vivo Transduction of Thymic Dendritic Cells with Adenovirus and Its Potential Use in Acute Inflammatory Diseases. Scandinavian Journal of Immunology. 61(4). 309–315. 3 indexed citations

16.

Brockstedt, Dirk G., Keith S. Bahjat, Martin Giedlin, et al.. (2005). Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nature Medicine. 11(8). 853–860. 114 indexed citations

17.

Brockstedt, Dirk G., Mojca Škoberne, Alice Yewdall, et al.. (2004). Killed but Metabolically Active Recombinant Listeria monocytogenes as an Antigen Delivery and Activation Platform for Human Dendritic Cell-Based Cancer Immunotherapy.. Blood. 104(11). 3447–3447. 2 indexed citations

18.

Oberholzer, Andreas, Caroline Oberholzer, Keith S. Bahjat, et al.. (2002). Increased Survival in Sepsis by In Vivo Adenovirus-Induced Expression of IL-10 in Dendritic Cells. The Journal of Immunology. 168(7). 3412–3418. 49 indexed citations

19.

Bahjat, Keith S., et al.. (2000). Autoregulation of Human Monocyte-Derived Dendritic Cell Maturation and IL-12 Production by Cyclooxygenase- 2-Mediated Prostanoid Production. The Journal of Immunology. 165(8). 4298–4304. 65 indexed citations

20.

Schowengerdt, Kenneth O., et al.. (2000). INCREASED EXPRESSION OF THE LYMPHOCYTE EARLY ACTIVATION MARKER CD69 IN PERIPHERAL BLOOD CORRELATES WITH HISTOLOGIC EVIDENCE OF CARDIAC ALLOGRAFT REJECTION1. Transplantation. 69(10). 2102–2107. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact